{"id":637,"date":"2014-07-19T15:10:19","date_gmt":"2014-07-19T19:10:19","guid":{"rendered":"http:\/\/allphasepharma.com\/dir\/?p=637"},"modified":"2014-09-29T12:19:40","modified_gmt":"2014-09-29T16:19:40","slug":"antibiotics-with-ocular-toxicity","status":"publish","type":"post","link":"https:\/\/allphasepharma.com\/dir\/2014\/07\/19\/637\/antibiotics-with-ocular-toxicity\/","title":{"rendered":"Antibiotics with Ocular Toxicity"},"content":{"rendered":"

The recent discussion whether fluoroquinolones (FQ) cause retinal detachment was short-lived and soon put to rest.\u00a0\u00a0 The issue was raised by 2 observational studies but no signal was seen in a larger and better designed\u00a0 Danish study.\u00a0 So it seems the association is probably spurious [i].\"smiley-150838_640\"<\/a>
\n<\/a>
\n<\/a><\/p>\n

At first blush such an association is quite possible and imaginable:\u00a0 First, there is the well-known ocular toxicity of chloroquine which has structural similarities to the quinolone nucleus.\u00a0 Likewise, the fact that FQs have a high affinity to pigmented tissues in the retina and elsewhere makes this a reasonable connection and possible concern.<\/p>\n

But as so often is the case, not all theoretical concerns are real; we now have some 30 years of experience with quinolones and if an adverse event has escaped us in all these years, it is likely to be a very rare bird.<\/p>\n

Nonetheless, this serves as a reminder to review the list of antibiotics with known toxic effects on the eye.<\/p>\n\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
Drug<\/th>Ocular Symptoms<\/th>Indication<\/th>MoA<\/th>Comments<\/th>\n<\/tr>\n<\/thead>\n
Ethambutol<\/td>Optic neuritis, visual field defects, color vision changes<\/td>M. tuberculosis<\/td>affinity to pigmented epithelia; chelation of copper?<\/td>Irreversible; dose-dependent; color vision changes after 2-8 mo of Rx; risk = dose-related<\/td>\n<\/tr>\n
Linezolid<\/td>Optic neuritis<\/td>Gram-positive antibacterial<\/td>disruption of mitochondrial function?<\/td>After prolonged administration only; partially reversible<\/td>\n<\/tr>\n
INH \/ isoniazid<\/td>Optic neuritis<\/td>M. tuberculosis<\/td>vitamin B6 deficiency?<\/td>Reversible; pyridoxine (vitamin B6)may be beneficial<\/td>\n<\/tr>\n
Chloroquine<\/td>Retinal toxicity; corneal deposits<\/td>malaria, rheumatoid arthritis<\/td>binding to melanin in pigmented retinal cells<\/td>More problematic with long-term use like for RA; chloroquine has higher risk than hydroxychloroquine; usually irreversible;<\/td>\n<\/tr>\n
Voriconazole<\/td>Abnormal vision, chromatopsia, photophobia, visual hallucinations, optic neuritis , papilledema<\/td>antifungal<\/td>unknown<\/td>Abnormal vision very common (19%), reversible after drug discontinuation<\/td>\n<\/tr>\n
Minocycline<\/td>Papilledema<\/td>acne<\/td>increased intracranial pressure<\/td>\u2018pseudotumor cerebri\u2019 usually reversible<\/td>\n<\/tr>\n
Rifampin \/ Rifampicin<\/td>Yellow discoloration of tears, anterior uveitis<\/td>M. tuberculosis<\/td>drug has intensely red color<\/td>More a nuisance than a toxicity<\/td>\n<\/tr>\n
Cidofovir<\/td>Uveitis, hypotony<\/td>CMV<\/td>unknown<\/td>Iritis can be treated with steroids + cycloplegic medx<\/td>\n<\/tr>\n
Sulfonamides<\/td>Myopic shift<\/td>broad-spectrum antibacterial<\/td><\/td><\/td>\n<\/tr>\n
Amantadine<\/td>Corneal edema<\/td>influenza A \/ Parkinson\u2019s<\/td>unknown; lower endothelial cell density?<\/td>Reversible after discontinuation<\/td>\n<\/tr>\n
Tetracyclines<\/td>Optic neuropathy<\/td>broad-spectrum antibacterial<\/td>increased intracranial pressure<\/td>\u2018Pseudotumor cerebri\u2019 usually reversible<\/td>\n<\/tr>\n
Interferons<\/td>Decrease or loss of vision, retinopathy including macular edema, retinal artery or vein thrombosis, retinal hemorrhages and cotton wool spots, optic neuritis, papilledema and serous retinal detachment<\/td>HCV<\/td>unknown \/ ischemia<\/td>Interferon associated Retinopathy in 19% to 69% of adults; in most cases reversible<\/td>\n<\/tr>\n
Clofazamine<\/td>Bull\u2019s eye maculopathy<\/td>leprosy<\/td><\/td><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n

NOTES:<\/p>\n

    \n
  • Voriconazole is a drug very often associated with visual complaints.\u00a0 It is prudent to inform patients about this before the 1st<\/sup> dose.<\/li>\n
  • Linezolid (LZD) is often prescribed for > 14 days, e.g. in cases of vertebral osteomyelitis when surgery and other antibiotics are not an option.\u00a0 The long-term safety of LZD is less well known but bone marrow toxicity, neuropathy and optic neuritis should be monitored.\u00a0 Therapeutic Drug Monitoring (TDM) may be useful to reduce the risk of adverse events.<\/li>\n
  • With ethambutol administration, ophthalmologic exams at baseline and during Rx are mandatory<\/li>\n<\/ul>\n
    \n

    General References:<\/strong><\/p>\n

    Wren. Journal of Behavioral Optometry\u00a0 Volume 11\/2000\/Number 6\/Page 149
    \nZegans\u00a0 Clinical Ocular Toxicology: Drugs, Chemicals, and Herbs<\/p>\n

    \n

    Reference:<\/strong><\/p>\n

    [i] Uptodate.\u00a0 http:\/\/www.uptodate.com\/contents\/fluoroquinolones?source=see_link&anchor=H142842158#H142842158<\/p>\n","protected":false},"excerpt":{"rendered":"

    The recent discussion whether fluoroquinolones (FQ) cause retinal detachment was short-lived and soon put to rest.\u00a0\u00a0 The issue was raised by 2 observational studies but no signal was seen in a larger and better designed\u00a0 Danish study.\u00a0 So it seems the association is probably spurious [i].<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[3],"tags":[393,395,403,35,397,391,224,390,119,392,389,401,398,399,402,394,141,400],"class_list":["post-637","post","type-post","status-publish","format-standard","hentry","category-the_news","tag-adverse-event","tag-amantadine","tag-antibiotic-blog","tag-cidofovir","tag-color-vision-change","tag-ethambutol","tag-fluoroquinolone","tag-inh","tag-interferon","tag-minocycline","tag-ocular-toxicity","tag-optic-neuropathy","tag-pa","tag-papilledema","tag-retinal-toxicity","tag-rifampin","tag-sulfonamide","tag-uveitis"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_shortlink":"https:\/\/wp.me\/p4KWFr-ah","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":1279,"url":"https:\/\/allphasepharma.com\/dir\/2015\/02\/23\/1279\/discontinued-but-not-forgotten-hcv-drugs-that-did-not-make-it\/","url_meta":{"origin":637,"position":0},"title":"Discontinued But Not Forgotten: HCV Drugs That Did Not Make It","author":"Harald","date":"February 23, 2015","format":false,"excerpt":"I find it useful to look back and review drug candidates that were stopped in development.\u00a0 In case of insufficient efficacy, i.e., not enough of a VL reduction or early viral rebound, everyone can sympathize with the decision to discontinue a drug. More importantly, we want to learn about the\u2026","rel":"","context":"In "Recent Literature"","block_context":{"text":"Recent Literature","link":"https:\/\/allphasepharma.com\/dir\/category\/recent_literature\/"},"img":{"alt_text":"Commandments","src":"https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2015\/02\/Commandments.jpg?resize=350%2C200","width":350,"height":200},"classes":[]},{"id":378,"url":"https:\/\/allphasepharma.com\/dir\/2014\/06\/23\/378\/fighting-p-aeruginosa-part-i\/","url_meta":{"origin":637,"position":1},"title":"Fighting P. aeruginosa (Part I)","author":"Harald","date":"June 23, 2014","format":false,"excerpt":"It has never been easy to cure Pseudomonas aeruginosa infections.\u00a0 Few antibiotics nowadays have reliable activity against this problem pathogen that seems to have more built-in resistance features than most other Gram-negatives.\u00a0 In the past, cephalosporins, aztreonam, penems, ciprofloxacin, and aminoglycosides were useful drugs with reliably cidal activity, especially when\u2026","rel":"","context":"In "The News"","block_context":{"text":"The News","link":"https:\/\/allphasepharma.com\/dir\/category\/the_news\/"},"img":{"alt_text":"PA-01 on Agar","src":"https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2014\/06\/PA-01-on-Agar-300x274.jpg?resize=350%2C200","width":350,"height":200},"classes":[]},{"id":2998,"url":"https:\/\/allphasepharma.com\/dir\/2017\/01\/12\/2998\/omissions-commissions-errors-blunders-solithromycin\/","url_meta":{"origin":637,"position":2},"title":"Omissions \u2013 Commissions \u2013 Errors \u2013 Blunders – Solithromycin","author":"Harald","date":"January 12, 2017","format":false,"excerpt":"Cempra received a complete response letter (CRL) as a X-mas present from FDA, and the news was pretty bad for company investors. Bad, but not totally unexpected after the AMDAC meeting last November, which taught us a few new things about the drug. It also highlighted how strategic missteps can\u2026","rel":"","context":"In "QIDP Antibiotics"","block_context":{"text":"QIDP Antibiotics","link":"https:\/\/allphasepharma.com\/dir\/category\/qidp_antibiotic\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2017\/01\/Solithro-Ketek-slider.jpg?resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2017\/01\/Solithro-Ketek-slider.jpg?resize=350%2C200 1x, https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2017\/01\/Solithro-Ketek-slider.jpg?resize=525%2C300 1.5x"},"classes":[]},{"id":689,"url":"https:\/\/allphasepharma.com\/dir\/2014\/08\/04\/689\/some-thoughts-about-eravacycline-based-on-the-phase-2-ciai-study\/","url_meta":{"origin":637,"position":3},"title":"Some Thoughts about Eravacycline Based on the Phase 2 cIAI Study","author":"Harald","date":"August 4, 2014","format":false,"excerpt":"Solomkin et al. conclude that the efficacy and safety of eravacycline compares favorably to the control drug, ertapenem.[1]\u00a0 This top-level assessment is made with the usual caveats (insufficient statistical power, small sample size), but a few points deserve comment. Eravacycline is a fluorocycline; as a tetracycline derivative it follows into\u2026","rel":"","context":"In "QIDP Antibiotics"","block_context":{"text":"QIDP Antibiotics","link":"https:\/\/allphasepharma.com\/dir\/category\/qidp_antibiotic\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2014\/08\/eravacycline-copy.jpg?fit=481%2C212&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":3100,"url":"https:\/\/allphasepharma.com\/dir\/2017\/01\/24\/3100\/kill-mocking-bug-cre-crab-variety\/","url_meta":{"origin":637,"position":4},"title":"To Kill A Mocking Bug – of the CRKP or CRAB Variety","author":"Harald","date":"January 24, 2017","format":false,"excerpt":"Meropenem stands out as an antibiotic to be used first in ESBL and MDR infections, given its efficacy profile and safety record (see earlier blog). It also would seem to be appropriate to use relatively high doses or prolonged infusion times \u2013 or both - to improve T>MIC for the\u2026","rel":"","context":"In "Recent Literature"","block_context":{"text":"Recent Literature","link":"https:\/\/allphasepharma.com\/dir\/category\/recent_literature\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2017\/01\/Mero-slider.jpg?resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2017\/01\/Mero-slider.jpg?resize=350%2C200 1x, https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2017\/01\/Mero-slider.jpg?resize=525%2C300 1.5x"},"classes":[]},{"id":2862,"url":"https:\/\/allphasepharma.com\/dir\/2016\/11\/07\/2862\/profiling-solithromycin-fda-amdac-on-solithera\/","url_meta":{"origin":637,"position":5},"title":"Profiling Solithromycin: FDA AMDAC on Solithera","author":"Harald","date":"November 7, 2016","format":false,"excerpt":"Police profiling based on race, sex or gender is a highly controversial practice. FDA doing the same, not so much. Profiling based on similarities to other drugs in the same category is nothing new. Class labeling can be expected for the next new B-lactam or quinolone regardless of whether during\u2026","rel":"","context":"In "QIDP Antibiotics"","block_context":{"text":"QIDP Antibiotics","link":"https:\/\/allphasepharma.com\/dir\/category\/qidp_antibiotic\/"},"img":{"alt_text":"solithro-pipe-magritte","src":"https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2016\/11\/Solithro-Pipe-Magritte.jpg?resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2016\/11\/Solithro-Pipe-Magritte.jpg?resize=350%2C200 1x, https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2016\/11\/Solithro-Pipe-Magritte.jpg?resize=525%2C300 1.5x"},"classes":[]}],"jetpack_likes_enabled":true,"_links":{"self":[{"href":"https:\/\/allphasepharma.com\/dir\/wp-json\/wp\/v2\/posts\/637","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/allphasepharma.com\/dir\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/allphasepharma.com\/dir\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/allphasepharma.com\/dir\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/allphasepharma.com\/dir\/wp-json\/wp\/v2\/comments?post=637"}],"version-history":[{"count":5,"href":"https:\/\/allphasepharma.com\/dir\/wp-json\/wp\/v2\/posts\/637\/revisions"}],"predecessor-version":[{"id":962,"href":"https:\/\/allphasepharma.com\/dir\/wp-json\/wp\/v2\/posts\/637\/revisions\/962"}],"wp:attachment":[{"href":"https:\/\/allphasepharma.com\/dir\/wp-json\/wp\/v2\/media?parent=637"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/allphasepharma.com\/dir\/wp-json\/wp\/v2\/categories?post=637"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/allphasepharma.com\/dir\/wp-json\/wp\/v2\/tags?post=637"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}